news Novo Nordisk partners with OpenAI as AI drug discovery hopes mount By AdminApril 14, 2026Less 1 min read85 Views0 The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs. ShareTweetPinShare Previous PostAsia markets mostly higher amid hopes of a U.S.-Iran deal; China exports miss estimates Next PostEuropean markets rise on hopes that Iran peace talks can resume Leave a Reply Your email address will not be published. Required fields are marked * Save my name, email, and website in this browser for the next time I comment. You May Also Like July 30, 20260 Comments DOJ holds first-ever hearing of ‘Alien Terrorist Removal Court,’ created in 1996 November 17, 20250 Comments Bangladesh Court Sentences Former Prime Minister to Death April 1, 20260 Comments Eli Lilly secures long-awaited FDA approval for its obesity pill. Here’s what to know February 22, 20260 Comments Inside Iran’s Preparation for War and Plans for Survival
July 30, 20260 Comments DOJ holds first-ever hearing of ‘Alien Terrorist Removal Court,’ created in 1996
April 1, 20260 Comments Eli Lilly secures long-awaited FDA approval for its obesity pill. Here’s what to know